Medical and Pharmaceutical Propanc Biopharma skyrockets from pancreatic cancer drug breakthrough Stock ascended by more than 150% Rowan Dunne2 days ago
Medical and Pharmaceutical Young Muay Thai fighter’s lung cancer death raises screening eligibility concerns Many heavy smokers live into their senior years while others are taken far too young Rowan Dunne6 days ago
Medical and Pharmaceutical Craif raises US$33M to get its urine cancer test into American clinics Milestone follows the firm opening a California lab in April Rowan DunneAugust 20, 2026
Medical and Pharmaceutical Moderna ascends more than 175% from cancer vaccine breakthrough It marks the first successful Phase 3 trial for an mRNA-based cancer therapy Rowan DunneAugust 20, 2026
Medical and Pharmaceutical Research shines light on efficacy of ‘Inflammacheck’ lung cancer breath test Small study yielded high accuracy, though larger-scale validation is still needed Rowan DunneAugust 19, 2026
Medical and Pharmaceutical Freenome gets FDA breakthrough designation for ‘SimpleScreen’ lung cancer blood test Achievement builds on firm securing agency's approval for a colorectal cancer test variation Rowan DunneAugust 13, 2026
Medical and Pharmaceutical Median Technologies partners with Canon Medical to achieve lung cancer screening goals Their collaboration seeks to expedite deployment of Median's AI-powered nodule detection system Rowan DunneJuly 31, 2026
Medical and Pharmaceutical Stand Up To Cancer charity funds non-invasive lung cancer screening projects It will provide up to US$200K for each of the three initiatives Rowan DunneJuly 29, 2026
Medical and Pharmaceutical Replimune tanks on FDA concerns about its skin cancer therapy Shares slid by more than 37% at the intraday low on Tuesday Rowan DunneJuly 29, 2026
Medical and Pharmaceutical Cizzle Biotech rises 16% from U.S. launch of lung cancer blood test The CIZ1B test is meant to complement LDCT in detecting early-stage disease Rowan DunneJuly 23, 2026